Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2025 13:24 ET | Source: Herantis Pharma plc

Herantis Pharma presents positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease

Herantis Pharma announces positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease Trial meets all primary and secondary endpoints establishing a strong...
August 21, 2025 01:19 ET | Source: Herantis Pharma plc

Herantis Pharma releases 1H 2025 report today

Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025...
August 14, 2025 09:02 ET | Source: Herantis Pharma plc

Last patient visit completed on schedule in Phase 1b clinical trial of HER-096 for Parkinson’s disease

Patient visits are now complete in the final cohort of Phase 1b trial, consisting of Parkinson’s disease patients receiving 300 mg doses of HER-096 or placebo twice weekly over a four-week...
May 13, 2025 02:05 ET | Source: Herantis Pharma plc

First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease

Herantis Pharma Plc – Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease HER-096 is a first-in-class agent in development for the...